Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma

Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common malignancies globally. Each year, more than 500,000 people worldwide are diagnosed with HCC. The onset of HCC is typically unnoticeable, and the prognosis is usually poor. The early diagnosis of HCC and dynamic monitoring of this disease can contribute to more effective therapeutic interventions and improve patient outcomes. To achieve ea...

Noninvasive diagnosis of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the 6th most common cancer in the world and the third most common malignant tumor following stomach and lung cancers in Korea. Approximately 90% of HCCs are associated with a known underlying risk factor. The most frequent risk factors include chronic viral hepatitis (hepatitis B virus, hepatitis C virus) and alcohol intake. Cirrhosis is an important risk facto...

Hepatocellular Carcinoma in Sheep

Biomarkers for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The HCC diagnosis is usually achieved by biomarkers, which can also help in prognosis prediction. Furthermore, it might represent certain therapeutic interventions through some combinations of biomarkers. Here, we review on our current understanding of HCC biomarkers.

Biomarkers for Hepatocellular Carcinoma

The hepatocellular carcinoma (HCC) is one of the most common malignant tumors and carries a poor survival rate. The management of patients at risk for developing HCC remains challenging. Increased understanding of cancer biology and technological advances have enabled identification of a multitude of pathological, genetic, and molecular events that drive hepatocarcinogenesis leading to discover...